Humana (NYSE:HUM) Hits New 1-Year Low - Time to Sell?

Humana Inc. (NYSE:HUM - Get Free Report) shares reached a new 52-week low during mid-day trading on Friday . The stock traded as low as $206.87 and last traded at $216.86, with a volume of 1428329 shares. The stock had previously closed at $223.55.

Analyst Upgrades and Downgrades

HUM has been the topic of several research analyst reports. Wells Fargo & Company set a $348.00 target price on shares of Humana in a research report on Friday. Bank of America reduced their price target on shares of Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research report on Tuesday, June 17th. Robert W. Baird lifted their price target on shares of Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research report on Tuesday, April 15th. Mizuho lifted their price target on shares of Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Finally, Oppenheimer lifted their price target on shares of Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a research report on Thursday, May 1st. Sixteen investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $282.57.

Humana Trading Down 1.6%

The company has a market cap of $26.56 billion, a price-to-earnings ratio of 15.56, a P/E/G ratio of 1.51 and a beta of 0.44. The firm's fifty day moving average price is $234.87 and its 200-day moving average price is $257.26. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.91 and a quick ratio of 1.91.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping the consensus estimate of $10.07 by $1.51. The business had revenue of $32.11 billion during the quarter, compared to the consensus estimate of $32 billion. Humana had a net margin of 1.42% and a return on equity of 14.47%. The company's quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $7.23 earnings per share. On average, equities analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Institutional Investors Weigh In On Humana

Several hedge funds and other institutional investors have recently bought and sold shares of the business. denkapparat Operations GmbH acquired a new stake in Humana during the 4th quarter worth about $323,000. Allstate Corp acquired a new stake in Humana during the 4th quarter worth about $905,000. Deutsche Bank AG raised its holdings in Humana by 18.2% during the 4th quarter. Deutsche Bank AG now owns 631,371 shares of the insurance provider's stock worth $160,185,000 after buying an additional 97,071 shares during the period. Janney Montgomery Scott LLC acquired a new stake in Humana during the 1st quarter worth about $1,309,000. Finally, Fred Alger Management LLC acquired a new stake in Humana during the 4th quarter worth about $451,000. 92.38% of the stock is currently owned by institutional investors.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.